Aprepitant for the control of delayed nausea and vomiting associated with the use of high-dose melphalan for autologous peripheral blood stem cell transplants in patients with multiple myeloma: a phase II study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer May, 2014 | Pubmed ID: 24838259